N-glycosylation stabilizes MerTK and promotes hepatocellular carcinoma tumor growth-Reference-Cited by-同舟云学术

N-glycosylation stabilizes MerTK and promotes hepatocellular carcinoma tumor growth

Published:2022-08 Issue: Volume:54 Page:102366
ISSN:2213-2317
Container-title:Redox Biology
language:en
Short-container-title:Redox Biology

Author:

Liu Yongzhang,Lan Linhua,Li Yujie,Lu Jing,He Lipeng,Deng Yao,Fei Mingming,Lu Jun-Wan,Shangguan Fugen,Lu Ju-Ping,Wang Jiaxin,Wu Liang,Huang Kate,Lu Bin^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Biochemistry,Clinical Biochemistry

Reference55 articles.

1. Hepatocellular carcinoma;Forner;Lancet,2012

2. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015

3. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA A Cancer J. Clin.,2021

4. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study;Tagger;Int. J. Cancer,1999

5. Risk factors for hepatocellular carcinoma among patients with chronic liver disease;Tsukuma;N. Engl. J. Med.,1993

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours;Oncogene;2024-08-23

2. Crosstalk between metabolism and cell death in tumorigenesis;Molecular Cancer;2024-04-04

3. Integrating single-cell and bulk sequencing data to identify glycosylation-based genes in non-alcoholic fatty liver disease-associated hepatocellular carcinoma;PeerJ;2024-03-18

4. Comprehensive assessment of TECENTRIQ® and OPDIVO®: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular carcinoma;Cancer and Metastasis Reviews;2024-02-27

5. Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma;Cell Reports Medicine;2024-02